Histone deacetylase 11 as a key regulator of metabolism and obesity.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 30126820.
- Also identified by DOI 10.1016/j.ebiom.2018.08.008 and PMC identifier 6154867.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this thought commentary, I highlight the discoveries made by Seto and colleagues related to HDAC11 and obesity. I discuss how their reported work fills a gap in the HDAC field and comment on the clinical implications of their findings. Overall, selective inhibition of HDAC11 could be a novel potential therapeutic avenue for both obesity and diabesity, the diabetes caused by obesity. Future studies to further dissect this mechanistic link between HDAC11 and metabolic programs will pave the way for designing mechanism-based combination therapeutic strategies for these two life style diseases.
Medical subject headings
- Histone Deacetylases
- Obesity